{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:00:57Z","timestamp":1789563657138,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"vor","delay-in-days":382,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["slas-discovery.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["SLAS Discovery"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1177\/2472555220973597","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T01:15:42Z","timestamp":1605748542000},"page":"336-344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["CETSA MS Profiling for a Comparative Assessment of FDA-Approved Antivirals Repurposed for COVID-19 Therapy Identifies TRIP13 as a Remdesivir Off-Target"],"prefix":"10.1016","volume":"26","author":[{"given":"Tomas","family":"Friman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7709-0161","authenticated-orcid":false,"given":"Alexey","family":"Chernobrovkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Martinez Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6785-1035","authenticated-orcid":false,"given":"Laurence","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1177\/2472555220973597_bib1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4014\/jmb.2003.03011","article-title":"Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19)","volume":"30","author":"Ahn","year":"2020","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1177\/2472555220973597_bib2","doi-asserted-by":"crossref","first-page":"117627","DOI":"10.1016\/j.lfs.2020.117627","article-title":"Virtual Screening and Repurposing of FDA Approved Drugs against COVID-19 Main Protease","volume":"251","author":"Kandeel","year":"2020","journal-title":"Life Sci."},{"key":"10.1177\/2472555220973597_bib3","first-page":"1","article-title":"An Update on Current Therapeutic Drugs Treating COVID-19","volume":"11","author":"Wu","year":"2020","journal-title":"Curr. Pharmacol. Rep."},{"key":"10.1177\/2472555220973597_bib4","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/ddr.21666","article-title":"COVID-19 Treatment by Repurposing Drugs until the Vaccine Is in Sight","volume":"81","author":"Phadke","year":"2020","journal-title":"Drug Dev. Res."},{"key":"10.1177\/2472555220973597_bib5","doi-asserted-by":"crossref","unstructured":"Laise P., Bosker G., Sun X.; et al. The Host Cell ViroCheckpoint: Identification and Pharmacologic Targeting of Novel Mechanistic Determinants of Coronavirus-Mediated Hijacked Cell States. bioRxiv 2020. DOI: 10.1101\/2020.05.12.091256.","DOI":"10.1101\/2020.05.12.091256"},{"key":"10.1177\/2472555220973597_bib6","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/s41557-020-0510-8","article-title":"Harder, Better, Faster","volume":"12","author":"Schultz","year":"2020","journal-title":"Nat. Chem."},{"key":"10.1177\/2472555220973597_bib7","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1111\/bcp.13294","article-title":"Pharmacogenomics of Off-Target Adverse Drug Reactions","volume":"83","author":"Garon","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1177\/2472555220973597_bib8","article-title":"Chemical Synthesis of Nucleoside 5\u2032-Triphosphate","volume":"37","author":"Vaghefi","year":"2006","journal-title":"ChemInform"},{"key":"10.1177\/2472555220973597_bib9","doi-asserted-by":"crossref","DOI":"10.1177\/2040206618758524","article-title":"Addressing the Selectivity and Toxicity of Antiviral Nucleosides","volume":"26","author":"Feng","year":"2018","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1177\/2472555220973597_bib10","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1021\/acscentsci.0c00489","article-title":"Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19","volume":"6","author":"Eastman","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1177\/2472555220973597_bib11","doi-asserted-by":"crossref","first-page":"1255784","DOI":"10.1126\/science.1255784","article-title":"Tracking Cancer Drugs in Living Cells by Thermal Profiling of the Proteome","volume":"346","author":"Savitski","year":"2014","journal-title":"Science"},{"key":"10.1177\/2472555220973597_bib12","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/nchembio.2185","article-title":"Thermal Profiling Reveals Phenylalanine Hydroxylase as an Off-Target of Panobinostat","volume":"12","author":"Becher","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1177\/2472555220973597_bib13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1233606","article-title":"Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay","volume":"341","author":"Martinez Molina","year":"2013","journal-title":"Science"},{"key":"10.1177\/2472555220973597_bib14","doi-asserted-by":"crossref","first-page":"eaau3174","DOI":"10.1126\/scitranslmed.aau3174","article-title":"Identifying Purine Nucleoside Phosphorylase as the Target of Quinine Using Cellular Thermal Shift Assay","volume":"11","author":"Dziekan","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1177\/2472555220973597_bib15","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1038\/s41596-020-0310-z","article-title":"Cellular Thermal Shift Assay for the Identification of Drug-Target Interactions in the Plasmodium falciparum Proteome","volume":"15","author":"Dziekan","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1177\/2472555220973597_bib16","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s41587-020-0528-x","article-title":"Biggest COVID-19 Trial Tests Repurposed Drugs First","volume":"38","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1177\/2472555220973597_bib17","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/d41587-020-00003-1","article-title":"Coronavirus Puts Drug Repurposing on the Fast Track","volume":"38","author":"Harrison","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1177\/2472555220973597_bib18","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1126\/science.abb9332","article-title":"Rapid Repurposing of Drugs for COVID-19","volume":"368","author":"Guy","year":"2020","journal-title":"Science (80-.)."},{"key":"10.1177\/2472555220973597_bib19","doi-asserted-by":"crossref","first-page":"105969","DOI":"10.1016\/j.ijantimicag.2020.105969","article-title":"Drug Repositioning Is an Alternative for the Treatment of Coronavirus COVID-19","volume":"55","author":"Serafin","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1177\/2472555220973597_bib20","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma Powers Differential Expression Analyses for RNA-Sequencing and Microarray Studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1177\/2472555220973597_bib21","doi-asserted-by":"crossref","unstructured":"Chernobrovkin A. L., Lengqvist J., K\u00f6rner C. C.; et al. In-Depth Characterization of Staurosporine Induced Proteome Thermal Stability Changes. bioRxiv 2020. DOI: 10.1101\/2020.03.13.990606.","DOI":"10.1101\/2020.03.13.990606"},{"key":"10.1177\/2472555220973597_bib22","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bbapap.2018.12.006","article-title":"A One-Pot Analysis Approach to Simplify Measurements of Protein Stability and Folding Kinetics","volume":"1867","author":"Liu","year":"2019","journal-title":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics."},{"key":"10.1177\/2472555220973597_bib23","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1128\/AAC.02350-13","article-title":"Metabolism and Pharmacokinetics of the Anti-Hepatitis C Virus Nucleotide Prodrug GS-6620","volume":"58","author":"Murakami","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1177\/2472555220973597_bib24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41556-019-0442-y","article-title":"TRIP13 Regulates DNA Repair Pathway Choice through REV7 Conformational Change","volume":"22","author":"Clairmont","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"10.1177\/2472555220973597_bib25","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.celrep.2017.05.021","article-title":"Mad2 Overexpression Uncovers a Critical Role for TRIP13 in Mitotic Exit","volume":"19","author":"Marks","year":"2017","journal-title":"Cell Rep."},{"key":"10.1177\/2472555220973597_bib26","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1042\/bj20031654","article-title":"Calcium-Dependent Regulation of Tumour Necrosis Factor-Alpha Receptor Signalling by Copine","volume":"378","author":"Tomsig","year":"2004","journal-title":"Biochem. J."},{"key":"10.1177\/2472555220973597_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cbi.2015.11.023","article-title":"Transcriptional Profiling Suggests That Nevirapine and Ritonavir Cause Drug Induced Liver Injury through Distinct Mechanisms in Primary Human Hepatocytes","volume":"255","author":"Terelius","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1177\/2472555220973597_bib28","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1161\/01.ATV.20.12.2625","article-title":"HIV Protease Inhibitors Stimulate Hepatic Triglyceride Synthesis","volume":"20","author":"Lenhard","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1177\/2472555220973597_bib29","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1046\/j.1365-2125.2000.00302.x","article-title":"The Intracellular Activation of Lamivudine (3TC) and Determination of 2\u2032-Deoxycytidine-5\u2032-Triphosphate (DCTP) Pools in the Presence and Absence of Various Drugs in HepG2 Cells","volume":"5","author":"Kewn","year":"2000","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1177\/2472555220973597_bib30","doi-asserted-by":"crossref","first-page":"26718","DOI":"10.18632\/oncotarget.14957","article-title":"TRIP13 Impairs Mitotic Checkpoint Surveillance and Is Associated with Poor Prognosis in Multiple Myeloma","volume":"8","author":"Tao","year":"2017","journal-title":"Oncotarget"}],"container-title":["SLAS Discovery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2472555220973597","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2472555220973597","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555222066898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555222066898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2472555220973597","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T11:52:54Z","timestamp":1762861974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2472555222066898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2472555222066898"],"URL":"https:\/\/doi.org\/10.1177\/2472555220973597","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.07.19.210492","asserted-by":"object"}]},"ISSN":["2472-5552"],"issn-type":[{"value":"2472-5552","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CETSA MS Profiling for a Comparative Assessment of FDA-Approved Antivirals Repurposed for COVID-19 Therapy Identifies TRIP13 as a Remdesivir Off-Target","name":"articletitle","label":"Article Title"},{"value":"SLAS Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1177\/2472555220973597","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 Society for Laboratory Automation and Screening. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}